Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Chiyoda Kohan

CREATE

Carchs Holdings

DAIKO DENSHI TSUSHIN

OSAKA KOHKI

TOKYO NISSAN COMPUTER SYSTEM

MEDIUS HOLDINGS

YAMASHITA MEDICAL INSTRUMENTS

CHARLE

TOKYO BOEKI

アマガサ

DAYTONA

SATORI ELECTRIC

KYODO PAPER HOLDINGS

小津産業

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Nittetsu Mining

Nissan Motor

日本セラミック

日本セラミック

日本セラミック

Financial Indicator Details: COSMO BIO COMPANY,LIMITED (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: COSMO BIO COMPANY,LIMITED (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Net profit margin (Industry Average)	2.59% (-0.67%)	5.58% (1.11%)	6.36% (1.04%)	5.67% (0.14%)
C/F margin (Industry Average)	12.43% (3.04%)	3.02% (2.58%)	12.23% (2.72%)	4.79% (3.01%)
ROA (Industry Average)	2.46% (-0.26%)	6.04% (2.02%)	6.80% (1.64%)	5.90% (1.86%)
ROE (Industry Average)	3.17% (-0.51%)	7.37% (4.78%)	8.57% (7.42%)	7.18% (10.52%)
Growth	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Equity growth (Industry Average)	- (-0.20%)	17.08% (8,903.19%)	5.65% (3.48%)	7.05% (7.03%)
Sales growth (Industry Average)	- (-)	26.39% (-8,084.01%)	7.72% (4.75%)	0.68% (2.25%)
Net profit growth (Industry Average)	- (93.72%)	172.26% (-53,131.49%)	22.78% (115.02%)	-10.26% (-35.44%)
Operating C/F growth (Industry Average)	- (285.33%)	-69.25% (-12,776.43%)	335.64% (137.06%)	-60.56% (277.80%)
Stability	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Capital adequacy (Industry Average)	77.72% (41.20%)	81.96% (42.85%)	79.34% (42.63%)	82.24% (44.26%)
Liquidity ratio (Industry Average)	408.78% (175.85%)	567.99% (180.41%)	482.05% (181.91%)	590.93% (188.36%)
C/F ratio current liabilities (Industry Average)	145.50% (1,315.76%)	411.38% (1,341.70%)	124.09% (2,369.89%)	263.97% (-1,473.15%)
Quick ratio (Industry Average)	296.65% (128.85%)	386.88% (130.25%)	328.66% (131.24%)	399.78% (134.71%)
Turnover	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Receivables turnover (Industry Average)	112.36day (72.58day)	122.19day (71.22day)	117.23day (74.24day)	116.99day (73.78day)
Inventory turnover (Industry Average)	31.09day (24.20day)	38.32day (24.10day)	36.99day (23.74day)	42.09day (23.74day)
Payable turnover (Industry Average)	30.26day (56.89day)	21.70day (53.81day)	21.31day (54.73day)	23.94day (54.15day)
Working capita turnover (Industry Average)	113.19day (39.89day)	138.81day (41.51day)	132.91day (43.25day)	135.14day (43.37day)
Stock etc.	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Market Value growth (Industry Average)	- (24.40%)	- (2.34%)	- (12.54%)	- (22.07%)
Dividend Yield (Industry Average)	- (2.43%)	- (2.57%)	- (2.50%)	- (2.29%)
PER (Industry Average)	- (-42,505.05%)	- (26.18%)	- (13.38%)	- (14.02%)
PBR (Industry Average)	- (2,493.11%)	- (0.75%)	- (0.75%)	- (0.94%)
PCFR (Industry Average)	- (-56,697.69%)	- (14.53%)	- (3.94%)	- (6.84%)
PSR (Industry Average)	- (627.96%)	- (0.27%)	- (0.27%)	- (0.36%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-12-31	2010-12-31	2011-12-31
Net profit margin (Industry Average)	1.81% (-7.87%)	6.40% (5.39%)	6.60% (-16.99%)
C/F margin (Industry Average)	- (0.24%)	- (0.42%)	- (0.40%)
ROA (Industry Average)	1.70% (1.12%)	6.14% (1.61%)	5.94% (1.68%)
ROE (Industry Average)	2.17% (2.42%)	7.40% (11.69%)	7.49% (3.68%)
Growth	2009-12-31	2010-12-31	2011-12-31
Equity growth (Industry Average)	- (2,759.04%)	6.21% (5.68%)	3.30% (4.49%)
Sales growth (Industry Average)	- (-)	2.31% (3.17%)	1.47% (-0.50%)
Net profit growth (Industry Average)	- (37,301.93%)	261.05% (18.43%)	4.66% (-18.89%)
Operating C/F growth (Industry Average)	- (34.97%)	- (107.23%)	- (419.92%)
Stability	2009-12-31	2010-12-31	2011-12-31
Capital adequacy (Industry Average)	78.10% (48.47%)	83.06% (49.17%)	79.21% (49.18%)
Liquidity ratio (Industry Average)	409.59% (209.41%)	515.88% (195.18%)	398.62% (184.34%)
C/F ratio current liabilities (Industry Average)	- (97.20%)	- (262.51%)	- (175.49%)
Quick ratio (Industry Average)	294.83% (148.93%)	347.65% (136.41%)	267.51% (108.70%)
Turnover	2009-12-31	2010-12-31	2011-12-31
Receivables turnover (Industry Average)	112.32day (103.30day)	108.22day (103.68day)	116.58day (84.78day)
Inventory turnover (Industry Average)	0.90day (17.21day)	0.61day (17.47day)	0.80day (9.13day)
Payable turnover (Industry Average)	30.38day (83.33day)	24.17day (85.88day)	25.37day (74.92day)
Working capita turnover (Industry Average)	82.85day (37.18day)	84.66day (35.27day)	92.02day (18.99day)
Stock etc.	2009-12-31	2010-12-31	2011-12-31
Market Value growth (Industry Average)	- (3.37%)	- (11.64%)	- (20.93%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.19%)	- (0.19%)
PER (Industry Average)	- (13.79%)	- (4.97%)	- (27.49%)
PBR (Industry Average)	- (0.97%)	- (0.96%)	- (1.20%)
PCFR (Industry Average)	- (3.88%)	- (-1.50%)	- (2.05%)
PSR (Industry Average)	- (1.83%)	- (2.08%)	- (2.31%)

Financial Indicator Details: COSMO BIO COMPANY,LIMITED

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Profitability
Net profit margin	2.59%	5.58%	6.36%	5.67%
C/F margin	12.43%	3.02%	12.23%	4.79%
ROA	2.46%	6.04%	6.80%	5.90%
ROE	3.17%	7.37%	8.57%	7.18%
Recurring margin	8.42%	9.51%	11.90%	11.06%
EBIT margin	8.40%	9.76%	12.22%	10.68%
EBITDA margin	9.21%	10.62%	13.08%	11.80%
NOPAT margin	5.04%	5.85%	7.33%	6.41%
Sales SG rates	59.03%	57.32%	55.72%	56.02%
Sales SG&A rates	32.31%	32.15%	31.86%	32.95%
Sales R&D expenses rates	-	-	-	-
Sales depreciation rates	0.81%	0.85%	0.86%	1.11%
Capital expenditures net sales ratio	-0.11%	-0.22%	-0.75%	-0.26%
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Growth
Growth rate of cash	-	-19.00%	30.51%	4.84%
Equity growth	-	17.08%	5.65%	7.05%
Total assets growth	-	11.03%	9.14%	3.28%
Sales growth	-	26.39%	7.72%	0.68%
Net profit growth	-	172.26%	22.78%	-10.26%
Operating C/F growth	-	-69.25%	335.64%	-60.56%
Recurring profit growth	-	42.69%	34.80%	-6.42%
EBIT growth	-	46.84%	34.81%	-11.94%
EBITDA growth	-	45.58%	32.72%	-9.13%
NOPAT growth	-	46.84%	34.81%	-11.94%
Operating expenses growth	-	-	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Stability
Capital adequacy	77.72%	81.96%	79.34%	82.24%
Liquidity ratio	408.78%	567.99%	482.05%	590.93%
C/F ratio current liabilities	145.50%	411.38%	124.09%	263.97%
Quick ratio	296.65%	386.88%	328.66%	399.78%
Fixed ratio	1.15%	3.22%	3.35%	3.11%
D/E ratio	0.46%	0.39%	0.37%	0.34%
Loan to Value Ratio	0.35%	0.32%	0.29%	0.28%
Business investment C/F ratio	-0.91%	-7.42%	-6.13%	-5.47%
Liabilities with interest growth	-	-	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Turnover
Cash turnover	83.61day	53.57day	64.91day	67.59day
Receivables turnover	112.36day	122.19day	117.23day	116.99day
Inventory turnover	31.09day	38.32day	36.99day	42.09day
Fixed assets turnover	3.45day	8.91day	9.08day	8.97day
Total asset turnover	384.00day	337.33day	341.75day	350.58day
Payable turnover	30.26day	21.70day	21.31day	23.94day
Capital turnover	63.43day	50.19day	46.58day	46.27day
Equity turnover	298.45day	276.48day	271.16day	288.33day
Working capita turnover	113.19day	138.81day	132.91day	135.14day
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Balance sheet
Cash etc.	¥ 1 B	¥ 980 M	¥ 1 B	¥ 1 B
Accounts receivable-trade	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Other Current Assets	¥ 2 B	¥ 3 B	¥ 3 B	¥ 4 B
Current Assets	¥ 3 B	¥ 4 B	¥ 5 B	¥ 5 B
Tangible Assets	¥ 50 M	¥ 163 M	¥ 179 M	¥ 178 M
Intangible Assets	¥ 172 M	¥ 191 M	¥ 213 M	¥ 162 M
Investment etc.	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Total Assets	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B
Current Liabilities	¥ 956 M	¥ 831 M	¥ 1 B	¥ 916 M
Fixed Liabilities	¥ 281 M	¥ 281 M	¥ 298 M	¥ 317 M
Liabilities with interest	¥ 20 M	¥ 20 M	¥ 20 M	¥ 20 M
Net Assets	¥ 4 B	¥ 5 B	¥ 5 B	¥ 5 B
Capital stock	¥ 918 M	¥ 918 M	¥ 918 M	¥ 918 M
Capital surplus etc.	¥ 3 B	¥ 4 B	¥ 4 B	¥ 4 B
Liabilities and net assets	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Income statement
Sales	¥ 5 B	¥ 6 B	¥ 7 B	¥ 7 B
Cost of Sales	¥ 3 B	¥ 3 B	¥ 4 B	¥ 4 B
Gross profit	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B
Other income	¥ 79 M	¥ 80 M	¥ 119 M	¥ 49 M
SG&A	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Other expenses	¥ 398 M	¥ 379 M	¥ 511 M	¥ 409 M
Net income	¥ 137 M	¥ 373 M	¥ 458 M	¥ 411 M
Operating income	¥ 456 M	¥ 701 M	¥ 891 M	¥ 798 M
Ordinary Income	¥ 445 M	¥ 635 M	¥ 856 M	¥ 801 M
EBITDA	¥ 487 M	¥ 709 M	¥ 941 M	¥ 855 M
Income before income taxes	¥ 444 M	¥ 652 M	¥ 879 M	¥ 774 M
Depreciation	¥ 43 M	¥ 57 M	¥ 62 M	¥ 81 M
R&D expenses	-	-	-	-
Income taxes	¥ 307 M	¥ 251 M	¥ 381 M	¥ 336 M
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Cash flow statement
Operating CF	¥ 657 M	¥ 202 M	¥ 880 M	¥ 347 M
Investment CF	¥ -383 M	¥ -334 M	¥ -351 M	¥ -167 M
Financial CF	¥ -66 M	¥ -93 M	¥ -232 M	¥ -126 M
Foreign Exchange Effects	¥ -2 M	¥ -4 M	¥ -7 M	¥ 8 M
Net Change in Cash	¥ 205 M	¥ -229 M	¥ 289 M	¥ 61 M
Free CF	¥ 274 M	¥ -132 M	¥ 529 M	¥ 180 M
Capital expenditures	¥ -6 M	¥ -15 M	¥ -54 M	¥ -19 M
Cash dividends paid	¥ -66 M	¥ -72 M	¥ -162 M	¥ -123 M
Repayment loans	-	¥ -20 M	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31	2012-12-31
Shareowners' equity
Issuance of new shares	-	-	-	-
Dividends from surplus	¥ -66 M	¥ -72 M	¥ -157 M	¥ -118 M
Net income	¥ 137 M	¥ 373 M	¥ 458 M	¥ 411 M
Purchase of treasury stock	-	-	¥ -67 M	-
Other Change in Stockholders Equity	-	-	-	-
Other Change in Net Assets	¥ 63 M	¥ 436 M	¥ 52 M	¥ 84 M
Net Change in Net Assets	¥ 134 M	¥ 737 M	¥ 286 M	¥ 377 M

Financial Indicator Details: COSMO BIO COMPANY,LIMITED

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-12-31	2010-12-31	2011-12-31
Profitability
Net profit margin	1.81%	6.40%	6.60%
C/F margin	-	-	-
ROA	1.70%	6.14%	5.94%
ROE	2.17%	7.40%	7.49%
Recurring margin	7.71%	10.02%	13.33%
EBIT margin	7.65%	10.35%	12.13%
EBITDA margin	7.65%	10.35%	12.13%
NOPAT margin	4.59%	6.21%	7.28%
Sales SG rates	59.25%	56.78%	54.81%
Sales SG&A rates	32.05%	31.72%	31.09%
Sales R&D expenses rates	-	-	-
Sales depreciation rates	-	-	-
Capital expenditures net sales ratio	-	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31
Growth
Growth rate of cash	-	-27.13%	13.80%
Equity growth	-	6.21%	3.30%
Total assets growth	-	-0.12%	8.31%
Sales growth	-	2.31%	1.47%
Net profit growth	-	261.05%	4.66%
Operating C/F growth	-	-	-
Recurring profit growth	-	32.92%	35.00%
EBIT growth	-	38.40%	18.91%
EBITDA growth	-	38.40%	18.91%
NOPAT growth	-	38.40%	18.91%
Operating expenses growth	-	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31
Stability
Capital adequacy	78.10%	83.06%	79.21%
Liquidity ratio	409.59%	515.88%	398.62%
C/F ratio current liabilities	-	-	-
Quick ratio	294.83%	347.65%	267.51%
Fixed ratio	1.00%	0.66%	0.96%
D/E ratio	0.45%	0.43%	0.41%
Loan to Value Ratio	0.35%	0.35%	0.33%
Business investment C/F ratio	-	-	-
Liabilities with interest growth	-	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31
Turnover
Cash turnover	82.43day	58.71day	65.84day
Receivables turnover	112.32day	108.22day	116.58day
Inventory turnover	0.90day	0.61day	0.80day
Fixed assets turnover	3.06day	2.11day	3.08day
Total asset turnover	389.24day	379.98day	405.60day
Payable turnover	30.38day	24.17day	25.37day
Capital turnover	63.96day	62.52day	61.61day
Equity turnover	304.02day	315.62day	321.30day
Working capita turnover	82.85day	84.66day	92.02day
Indicator	2009-12-31	2010-12-31	2011-12-31
Balance sheet
Cash etc.	¥ 1 B	¥ 862 M	¥ 981 M
Accounts receivable-trade	¥ 1 B	¥ 1 B	-
Other Current Assets	¥ 2 B	¥ 2 B	¥ 3 B
Current Assets	¥ 3 B	¥ 3 B	-
Tangible Assets	¥ 44 M	¥ 31 M	¥ 46 M
Intangible Assets	¥ 120 M	¥ 136 M	¥ 163 M
Investment etc.	¥ 1 B	¥ 1 B	¥ 1 B
Total Assets	¥ 5 B	¥ 5 B	¥ 6 B
Current Liabilities	¥ 948 M	¥ 705 M	¥ 1 B
Fixed Liabilities	¥ 274 M	¥ 240 M	¥ 239 M
Liabilities with interest	¥ 20 M	¥ 20 M	¥ 20 M
Net Assets	¥ 4 B	¥ 4 B	¥ 4 B
Capital stock	¥ 918 M	¥ 918 M	¥ 918 M
Capital surplus etc.	¥ 3 B	¥ 3 B	¥ 3 B
Liabilities and net assets	¥ 5 B	¥ 5 B	-
Indicator	2009-12-31	2010-12-31	2011-12-31
Income statement
Sales	¥ 5 B	¥ 5 B	¥ 5 B
Cost of Sales	¥ 3 B	¥ 3 B	¥ 2 B
Gross profit	¥ 2 B	¥ 2 B	¥ 2 B
Other income	¥ 39 M	¥ 52 M	¥ 63 M
SG&A	¥ 1 B	¥ 1 B	¥ 1 B
Other expenses	¥ 398 M	¥ 324 M	¥ 469 M
Net income	¥ 95 M	¥ 343 M	¥ 359 M
Operating income	¥ 455 M	¥ 615 M	¥ 765 M
Ordinary Income	¥ 404 M	¥ 537 M	¥ 725 M
EBITDA	¥ 401 M	¥ 555 M	¥ 660 M
Income before income taxes	¥ 402 M	¥ 555 M	-
Depreciation	-	-	-
R&D expenses	-	-	-
Income taxes	¥ 307 M	¥ 211 M	-
Indicator	2009-12-31	2010-12-31	2011-12-31
Cash flow statement
Operating CF	-	-	-
Investment CF	-	-	-
Financial CF	-	-	-
Foreign Exchange Effects	-	-	-
Net Change in Cash	-	-	-
Free CF	-	-	-
Capital expenditures	-	-	-
Cash dividends paid	-	-	-
Repayment loans	-	-	-
Indicator	2009-12-31	2010-12-31	2011-12-31
Shareowners' equity
Issuance of new shares	-	-	-
Dividends from surplus	¥ -66 M	¥ -72 M	-
Net income	¥ 95 M	¥ 343 M	-
Purchase of treasury stock	-	-	-
Other Change in Stockholders Equity	-	¥ -1 M	-
Other Change in Net Assets	¥ 63 M	-	-
Net Change in Net Assets	¥ 92 M	¥ 270 M	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: COSMO BIO COMPANY,LIMITED (Annual )

Statement Type

Annual : COSMO BIO COMPANY,LIMITED

First quarter : COSMO BIO COMPANY,LIMITED

Second quarter : COSMO BIO COMPANY,LIMITED

Third quarter : COSMO BIO COMPANY,LIMITED

Analysis Menu

Outline : COSMO BIO COMPANY,LIMITED

Statement : COSMO BIO COMPANY,LIMITED

Rating : COSMO BIO COMPANY,LIMITED

Indicator : COSMO BIO COMPANY,LIMITED

Download : COSMO BIO COMPANY,LIMITED

Industry Comparison Ranking

Wholesale Trade - EDIUNET Industry Rankings

Wholesale Trade - EDIUNET Credit Rating

Wholesale Trade - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo江東区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/20	リーバイ・ストラウス　..	C	2013-11-30
1/20	TIEMCO	BB	2013-11-30
1/15	イワキ	BBB	2013-11-30
1/15	マルカキカイ	BBB	2013-11-30
1/15	ALTECH	BB	2013-11-30
1/15	Shinwa	BBB	2013-11-30 (Q1)
1/15	ONWARD HOLDINGS	A	2013-11-30 (Q3)
1/15	ガリバーインターナショ..	BBB	2013-11-30 (Q3)
1/15	Morito	A	2013-11-30
1/15	BIKE O	BB→BBB	2013-11-30

EDIUNET Investment News (Wholesale Trade)

1/20 Wholesale Trade (リーバイ・..

1/15 Wholesale Trade (イワキ:BBB ..

1/10 Wholesale Trade (エコーＴＤ:..

1/9 Wholesale Trade (KITAKEI:BBB)

1/8 Wholesale Trade (F&A AQUA HO..

1/7 Wholesale Trade (Wakita:A)

1/6 Wholesale Trade (ADVAN:AA)

12/27 Wholesale Trade (ADVANCE:CC ..

12/26 Wholesale Trade (NAGAILEBEN:..

. Wholesale Trade (OOMITSU CO...

Company Information

Ticker	Market	Industry	Month	report	Rating
COSMO BIO COMPANY,LIMITED	3386	OSE JASDAQ	Wholesale Trade	12	Annual	AA

Related Company

DAIKO DENSHI TSUSHIN (Sales ¥ 33 B)

SANKYO KASEI (Sales ¥ 19 B)

KYODO PAPER HOLDINGS (Sales ¥ 17 B)

NARASAKI SANGYO (Sales ¥ 97 B)

CREATE (Sales ¥ 25 B)

Chiyoda Kohan (Sales ¥ 38 B)

ALBIS (Sales ¥ 62 B)

TOKYO NISSAN COMPUTER SYSTEM (Sales ¥ 9 B)

SATORI ELECTRIC (Sales ¥ 129 B)

COSMO BIO COMPANY,LIMITED (Sales ¥ 7 B)

OSAKA KOHKI (Sales ¥ 15 B)

ヤギ (Sales ¥ 113 B)

Carchs Holdings (Sales ¥ 30 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .